1.Investigation on the quantitative variation of the registered drugs for circulation by manufacturer’s establishments from 1996 to 2001
Pharmaceutical Journal 2003;321(1):11-13
Data of circulating registered medications of nationwide manufacturing centers from 1996 to 2001 was reviewed. The data was processed by common statistic methods with tests to compare between result group, using Epi-info software version 6.04. By 2001, the total of circulating medications were 6,875. 5,187 medications out of which is that of state businesses and 1,689 medications is that of out-of-state businesses. For types, both types of business have tend to seek the medications that give high benefit, as presented in structure of registration. Brand name drugs, herbals with new names and new formulations have tend to increase, compare to common and essential medications
Pharmaceutical Preparations
;
Drugs, Investigational
;
Evaluation Studies
2.Situation of drug buying of people in some provinces of the North of Vietnam
Pharmaceutical Journal 2001;298(2):6-8
An investigation of the drug buying situation of people in some provinces of the North of Vietnam has shown that there was a trend of use of multi drugs for a duration of treatment. The rate of drug buying according to the prescription was low of which the rate of resuse of prescription was high; 76% of users bought drugs as instruction of drug seller. The benefit impacted strongly on the behaviour and attitude of physicians, drug seller leading to prescription for many drugs, drug with expensive price. The pharmacy authorities should have solutions and communicate and educate the safe and rational use of drug use in the community.
Pharmaceutical Preparations
;
supply & distribution
3.Situation of pharmaceutical facilities which have drugs registered for circulation during 1996-2001
Pharmaceutical Journal 1998;272(12):5-8
The market economy impacted strongly on the drug production and business, the member of pharmaceutical production facilities in the north of Vietnam and in the South of Vietnam accounted for 25% and 75%, respectively. There was no difference of number of state pharmaceutical factories between two regions. The private pharmaceutical factories impacted by the financial and money crisis in the region, their number of drugs registered reduced a half
Pharmaceutical Preparations
;
Jurisprudence
4.Study complication of aplastic anemia following chemotherapy of acute myelogenous leukemia
Journal of Medical Research 2007;51(4):9-13
Background: Aplastic anemia following chemotherapy of acute leukemia is a common complication, which may lead to severe consequences. Objective: To study characteristics of aplastic anemia occurred in ccute myelogenous leukemia (AML) patients, following chemotherapy. Subjects and methods: A prospective study was carried out in 50 AML patients treated at National Institute of Hematology and Blood Transfusion from Aug 2005 to Dec 2006. These patients were treated by induction chemotherapy with "3+7" regime. Result: Aplastic anemia had been seen in 100% patients. Characteristics of this condition were poor marrow cells (average marrow cell count was 15.1\xb112.6 G/l) and strongly decreased counts of hemoglobin, white blood cells and platelets. Hemoglobin, white blood cell and platelet counts at the lowest level were 83.32 g/l; 0.96 G/l; 30.18 G/l; respectively. This situation prolonged for 3-4 weeks and changed into the most severe condition at the end of second week after chemotherapy. Infection frequency was 92%. Conclusion: Aplastic anemia following chemotherapy of AML patients is a common complication with severe consequences such as significant decrease of WBC and platelet counts, which may lead to opportunistic infection. Hence, this complication must be monitored, detected and treated promptly. \r\n', u'\r\n', u'
Leukemia
;
Myeloid
;
Acute/ pathology
;
prevention &
;
control
;
complications
;
drug therapy
;
Anemia
;
Aplastic/ blood
;
complications
;
pathology
5.The value of urocytogramme in normal menstruation period of adolescent girls
Yen Thi Thuy Hoang ; Nhan Thu Nguyen ; Hop Van Tran
Journal of Medical Research 2007;55(6):168-172
Background:The urocytogramme is a certain laboratory tests, although older. By studying the cellular elements from the wall of the bladder trigone desquamated in the urine, it allows cyto-hormonal diagnosis. It allows to assess the presence and importance of the biological effect of sex steroids. This examination is not commonly used because they are poorly known in our country. It's a review of how simple, noninvasive, inexpensive. Objectives:This study aims to learn about the value of urocytogramme in normal menstruation period of girls. Subjects and method:A study was conducted on 143 high school girls of Hai Ba Trung Secondary School, Hue city. The mean age was 15\xb18 months, completely puberty; the average weight was 45.7\xb16.8 kg; average height was 156.8 \xb18.5 cm. The duration of study was from September 2006 to May 2007. Results:Urocytogramme had the index which changed according to the phase of the menstrual cycle and correlated closely with sex hormone concentrations in the ovulatory phase. The IK index had the value in ovulation diagnostic phase with the sensitivity and specificity concentrations equivalent to LH and plasma Estradiol. Conclusion:Urocytogram was a useful test for the diagnosis of in normal menstruation period of adolescent girls. It was easy, cheap and truly reflected oestrogen activity to help doctors making decision for the treatment of lasting amenorrhea disorders.
Menstrual Cycle
;
Adolescent
6.Tomographic density imaging using modified DF–DBIM approach
Tran Quang HUY ; Nguyen Thi CUC ; Van Dung NGUYEN ; Ton That LONG ; Tran Duc TAN
Biomedical Engineering Letters 2019;9(4):449-465
Ultrasonic computed tomography based on back scattering theory is the most powerful and accurate tool in ultrasound based imaging approaches because it is capable of providing quantitative information about the imaged target and detects very small targets. The duple-frequency distorted Born iterative method (DF–DBIM), which uses density information along with sound contrast for imaging, is a promising approach for imaging targets at the level of biological tissues. With two frequencies f₁ (low) and f₂ (high) through Nf₁ and Nf₂ iterations respectively, this method is used to estimate target density along with sound contrast. The implications of duple-frequency fusion for the image reconstruction quality of density information along with sound contrast based ultrasound tomography have been analyzed in this paper. In this paper, we concentrate on the selection of parameters that is supposed to be the best to improve the reconstruction quality of ultrasound tomography. When there are restraints imposed on simulated scenarios to have control of the computational cost, the iteration number Nf₁ is determined resulting in giving the best performance. The DF–DBIM is only effective if there are a moderate number of iterations, transmitters and receivers. In case that the number of transducers is either too large or too small, a result of reconstruction which is better than that of the single frequency approach is not produced by the implementation of DF–DBIM. A fixed sum N(iter) of Nf₁ and Nf₂ was given, the investigation of simulation results shows that the best value of Nf₁ is [N(iter)/2 − 1]. The error, when applying this way of choosing the parameters, will be normalized with the reduction of 56.11%, compared to use single frequency as used in the conventional DBIM method. The target density along with sound contrast is used to image targets in this paper. It is a fact that low-frequency offers fine convergence, and high-frequency offers fine spatial resolution. Wherefore, this technique can effectively expand DBIM's applicability to the problem of biological tissue reconstruction. Thanks to the usage of empirical data, this work will be further developed prior to its application in reality.
Image Processing, Computer-Assisted
;
Methods
;
Transducers
;
Ultrasonics
;
Ultrasonography
7.Asia-Pacific consensus on long-term and sequential therapy for osteoporosis
Ta-Wei TAI ; Hsuan-Yu CHEN ; Chien-An SHIH ; Chun-Feng HUANG ; Eugene MCCLOSKEY ; Joon-Kiong LEE ; Swan Sim YEAP ; Ching-Lung CHEUNG ; Natthinee CHARATCHAROENWITTHAYA ; Unnop JAISAMRARN ; Vilai KUPTNIRATSAIKUL ; Rong-Sen YANG ; Sung-Yen LIN ; Akira TAGUCHI ; Satoshi MORI ; Julie LI-YU ; Seng Bin ANG ; Ding-Cheng CHAN ; Wai Sin CHAN ; Hou NG ; Jung-Fu CHEN ; Shih-Te TU ; Hai-Hua CHUANG ; Yin-Fan CHANG ; Fang-Ping CHEN ; Keh-Sung TSAI ; Peter R. EBELING ; Fernando MARIN ; Francisco Javier Nistal RODRÍGUEZ ; Huipeng SHI ; Kyu Ri HWANG ; Kwang-Kyoun KIM ; Yoon-Sok CHUNG ; Ian R. REID ; Manju CHANDRAN ; Serge FERRARI ; E Michael LEWIECKI ; Fen Lee HEW ; Lan T. HO-PHAM ; Tuan Van NGUYEN ; Van Hy NGUYEN ; Sarath LEKAMWASAM ; Dipendra PANDEY ; Sanjay BHADADA ; Chung-Hwan CHEN ; Jawl-Shan HWANG ; Chih-Hsing WU
Osteoporosis and Sarcopenia 2024;10(1):3-10
Objectives:
This study aimed to present the Asia-Pacific consensus on long-term and sequential therapy for osteoporosis, offering evidence-based recommendations for the effective management of this chronic condition.The primary focus is on achieving optimal fracture prevention through a comprehensive, individualized approach.
Methods:
A panel of experts convened to develop consensus statements by synthesizing the current literature and leveraging clinical expertise. The review encompassed long-term anti-osteoporosis medication goals, first-line treatments for individuals at very high fracture risk, and the strategic integration of anabolic and anti resorptive agents in sequential therapy approaches.
Results:
The panelists reached a consensus on 12 statements. Key recommendations included advocating for anabolic agents as the first-line treatment for individuals at very high fracture risk and transitioning to anti resorptive agents following the completion of anabolic therapy. Anabolic therapy remains an option for in dividuals experiencing new fractures or persistent high fracture risk despite antiresorptive treatment. In cases of inadequate response, the consensus recommended considering a switch to more potent medications. The consensus also addressed the management of medication-related complications, proposing alternatives instead of discontinuation of treatment.
Conclusions
This consensus provides a comprehensive, cost-effective strategy for fracture prevention with an emphasis on shared decision-making and the incorporation of country-specific case management systems, such as fracture liaison services. It serves as a valuable guide for healthcare professionals in the Asia-Pacific region, contributing to the ongoing evolution of osteoporosis management.